Pathology of gastrointestinal disorders

Endocrinology and Metabolism Clinics of North America

Volumn 39, Issue 4, 2010, Pages 713-727

  Rindi, Guido ^a   Inzani, Frediano ^a,b   Solcia, Enrico ^b  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Carcinoid; Dysplasia; Hyperplasia; Neoplasia; Neuroendocrine carcinoma; Neuroendocrine tumor

Indexed keywords

GASTRIN; SOMATOSTATIN;

ACHLORHYDRIA; APPENDECTOMY; CANCER GRADING; CANCER SURVIVAL; CARCINOID; ENTEROCHROMAFFIN CELL; ENTEROCHROMAFFIN LIKE CELL; ENTEROENDOCRINE CELL; GASTRECTOMY; GASTRIN CELL; GASTRINOMA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL DYSPLASIA; GASTROINTESTINAL TUMOR; GLUCAGONOMA; HISTOPATHOLOGY; HUMAN; HYPERGASTRINEMIA; HYPOGLYCEMIA; LIVER METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; PARAGANGLIOMA; PRIORITY JOURNAL; REVIEW; SOMATOSTATIN CELL; SOMATOSTATINOMA; ZOLLINGER ELLISON SYNDROME;

COLORECTAL NEOPLASMS; DUODENAL NEOPLASMS; DUODENUM; GASTROINTESTINAL DISEASES; GASTROINTESTINAL NEOPLASMS; HUMANS; HYPERPLASIA; ILEAL NEOPLASMS; ILEUM; STOMACH;

EID: 78649374327     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2010.08.009     Document Type: Review

References (99)

1. Jensen R.T. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas. Basic Clin Pharmacol Toxicol 2006, 98(1):4-19.
2. Bordi C., Gabrielli M., Missale G. Pathologic changes of endocrine cells in chronic atrophic gastritis. An ultrastructural study on peroral gastric biopsy specimens. Arch Pathol Lab Med 1978, 102(3):129-135.
3. Solcia E., Rindi G., Fiocca R., et al. Distinct patterns of chronic gastritis associated with carcinoid and cancer and their role in tumorigenesis. Yale J Biol Med 1992, 65(6):793-804. [discussion: 827-9].
4. Lamberts R., Creutzfeldt W., Struber H.G., et al. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 1993, 104(5):1356-1370.
5. Solcia E., Bordi C., Creutzfeldt W., et al. Histopathological classification of nonantral gastric endocrine growths in man. Digestion 1988, 41:185-200.
6. Solcia E., Capella C., Sessa F., et al. Gastric carcinoids and related endocrine growths. Digestion 1986, 35(Suppl 1):3-22.
7. Bordi C., Cocconi G., Togni R., et al. Gastric endocrine cell proliferation. Association with Zollinger-Ellison syndrome. Arch Pathol 1974, 98(4):274-278.
8. Solcia E., Capella C., Buffa R., et al. Identification, ultrastructure and classification of gut endocrine cells and related growths. Invest Cell Pathol 1980, 3(1):37-49.
9. Bordi C., Ferrari C., D'Adda T., et al. Ultrastructural characterization of fundic endocrine cell hyperplasia associated with atrophic gastritis and hypergastrinaemia. Virchows Arch A Pathol Anat Histopathol 1986, 409(3):335-347.
10. Bordi C., Yu J.Y., Baggi M.T., et al. Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer 1991, 67(3):663-672.
11. Srivastava A., Kamath A., Barry S.A., et al. Ghrelin expression in hyperplastic and neoplastic proliferations of the enterochromaffin-like (ECL) cells. Endocr Pathol 2004, 15(1):47-54.
12. Creutzfeldt W. The achlorhydria-carcinoid sequence: role of gastrin. Digestion 1988, 39(2):61-79.
13. D'Adda T., Corleto V., Pilato F.P., et al. Quantitative ultrastructure of endocrine cells of oxyntic mucosa in Zollinger-Ellison syndrome. Correspondence with light microscopic findings. Gastroenterology 1990, 99(1):17-26.
14. Bordi C., D'Adda T., Azzoni C., et al. Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol 1995, 19(Suppl 1):S8-19.
15. Arnold R., Hulst M.V., Neuhof C.H., et al. Antral gastrin-producing G-cells and somatostatin-producing D-cells in different states of gastric acid secretion. Gut 1982, 23(4):285-291.
16. Arnold R., Frank M., Simon B., et al. Adaptation and renewal of the endocrine stomach. Scand J Gastroenterol Suppl 1992, 193:20-27.
17. Polak J.M., Stagg B., Pearse A.G. Two types of Zollinger-Ellison syndrome: immunofluorescent, cytochemical and ultrastructural studies of the antral and pancreatic gastrin cells in different clinical states. Gut 1972, 13(7):501-512.
18. Keuppens F., Willems G., De Graef J., et al. Antral gastrin cell hyperplasia in patients with peptic ulcer. Ann Surg 1980, 191(3):276-281.
19. Friesen S.R., Tomita T. Pseudo-Zollinger-Ellison syndrome: hypergastrinemia, hyperchlorhydria without tumor. Ann Surg 1981, 194(4):481-493.
20. Annibale B., Bonamico M., Rindi G., et al. Antral gastrin cell hyperfunction in children. A functional and immunocytochemical report. Gastroenterology 1991, 101(6):1547-1551.
21. Rindi G., Annibale B., Bonamico M., et al. Helicobacter pylori infection in children with antral gastrin cell hyperfunction. J Pediatr Gastroenterol Nutr 1994, 18(2):152-158.
22. Solcia E., Capella C., Fiocca R., et al. Disorders of the endocrine system. Pathology of the gastrointestinal tract 1998, 295-322. Williams and Wilkins, Philadelphia. S.C. Ming, H. Goldman (Eds.).
23. Rindi G., Luinetti O., Cornaggia M., et al. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 1993, 104(4):994-1006.
24. Papotti M., Cassoni P., Volante M., et al. Ghrelin-producing endocrine tumors of the stomach and intestine. J Clin Endocrinol Metab 2001, 86(10):5052-5059.
25. Rindi G., Bordi C., Rappel S., et al. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg 1996, 20(2):168-172.
26. Quinonez G., Ragbeer M.S., Simon G.T. A carcinoid tumor of the stomach with features of a midgut tumor. Arch Pathol Lab Med 1988, 112(8):838-841.
27. Tsolakis A.V., Portela-Gomes G.M., Stridsberg M., et al. Malignant gastric ghrelinoma with hyperghrelinemia. J Clin Endocrinol Metab 2004, 89(8):3739-3744.
28. Rindi G., Kloppel G., Alhman H., et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006, 449(4):395-401.
29. Rindi G., Azzoni C., La Rosa S., et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 1999, 116(3):532-542.
30. Jiang S.X., Mikami T., Umezawa A., et al. Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity. Am J Surg Pathol 2006, 30(8):945-953.
31. Brenner B., Tang L.H., Klimstra D.S., et al. Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol 2004, 22(13):2730-2739.
32. Chiaravalli A.M., Klersy C., Tava F., et al. Lower- and higher-grade subtypes of diffuse gastric cancer. Hum Pathol 2009, 40(11):1591-1599.
33. Solcia E., Klersy C., Mastracci L., et al. A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis. Virchows Arch 2009, 455(3):197-211.
34. Rindi G., Kloppel G., Couvelard A., et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2007, 451(4):757-762.
35. Pape U.F., Jann H., Muller-Nordhorn J., et al. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 2008, 113(2):256-265.
36. Edge SB, Byrd DR, Compton CC, et al, editors. AJCC cancer staging manual 2010, Springer-Verlag, New York. 7th edition.
37. Hou W., Schubert M.L. Treatment of gastric carcinoids. Curr Treat Options Gastroenterol 2007, 10(2):123-133.
38. Ooi A., Ota M., Katsuda S., et al. An unusual case of multiple gastric carcinoids associated with diffuse endocrine cell hyperplasia and parietal cell hypertrophy. Endocr Pathol 1995, 6(3):229-237.
39. Abraham S.C., Carney J.A., Ooi A., et al. Achlorhydria, parietal cell hyperplasia, and multiple gastric carcinoids: a new disorder. Am J Surg Pathol 2005, 29(7):969-975.
40. Wangberg B., Grimelius L., Granerus G., et al. The role of gastric resection in the management of multicentric argyrophil gastric carcinoids. Surgery 1990, 108(5):851-857.
41. Berna M.J., Annibale B., Marignani M., et al. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors. J Clin Endocrinol Metab 2008, 93(5):1582-1591.
42. Bordi C., Falchetti A., Azzoni C., et al. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. Am J Surg Pathol 1997, 21(9):1075-1082.
43. Norton J.A., Melcher M.L., Gibril F., et al. Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment. Surgery 2004, 136(6):1267-1274.
44. Pizzi S., Azzoni C., Bassi D., et al. Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract. Cancer 2003, 98(6):1273-1282.
45. Furlan D., Bernasconi B., Uccella S., et al. Allelotypes and fluorescence in situ hybridization profiles of poorly differentiated endocrine carcinomas of different sites. Clin Cancer Res 2005, 11(5):1765-1775.
46. Anlauf M., Perren A., Meyer C.L., et al. Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas. Gastroenterology 2005, 128(5):1187-1198.
47. Merchant S.H., VanderJagt T., Lathrop S., et al. Sporadic duodenal bulb gastrin-cell tumors: association with Helicobacter pylori gastritis and long-term use of proton pump inhibitors. Am J Surg Pathol 2006, 30(12):1581-1587.
48. Anlauf M., Perren A., Henopp T., et al. Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions. Gut 2007, 56(5):637-644.
49. Rindi G., Leiter A.B., Kopin A.S., et al. The "normal" endocrine cell of the gut. Changing concepts and new evidences. Ann N Y Acad Sci 2004, 1014:1-12.
50. Capella C., Riva C., Rindi G., et al. Endocrine tumors of the duodenum and upper jejunum. A study of 33 cases with clinico-pathological characteristics and hormone content. Hepatogastroenterology 1990, 37(2):247-252.
51. Soga J., Tazawa K. Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases. Cancer 1971, 28(4):990-998.
52. Capella C., Riva C., Rindi G., et al. Histopathology, hormone products and clinico-pathologic profile of endocrine tumours of the upper small intestine. A study of 44 cases. Endocr Pathol 1991, 2:91-110.
53. Anlauf M., Garbrecht N., Henopp T., et al. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features. World J Gastroenterol 2006, 12(34):5440-5446.
54. Vinik A.I., McLeod M.K., Fig L.M., et al. Clinical features, diagnosis, and localization of carcinoid tumors and their management. Gastroenterol Clin North Am 1989, 18(4):865-896.
55. Burke A.P., Sobin L.H., Federspiel B.H., et al. Carcinoid tumors of the duodenum. A clinicopathologic study of 99 cases. Arch Pathol Lab Med 1990, 114(7):700-704.
56. Anlauf M., Enosawa T., Henopp T., et al. Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor. Am J Surg Pathol 2008, 32(7):1101-1105.
57. Hofmann J.W., Fox P.S., Wilson S.D. Duodenal wall tumors and the Zollinger-Ellison syndrome. Surgical management. Arch Surg 1973, 107(2):334-339.
58. Pipeleers-Marichal M., Somers G., Willems G., et al. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med 1990, 322(11):723-727.
59. Weber H.C., Venzon D.J., Lin J.T., et al. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 1995, 108(6):1637-1649.
60. Nassar H., Albores-Saavedra J., Klimstra D.S. High-grade neuroendocrine carcinoma of the ampulla of Vater: a clinicopathologic and immunohistochemical analysis of 14 cases. Am J Surg Pathol 2005, 29(5):588-594.
61. Cross S.S., Hughes A.D., Williams G.T., et al. Endocrine cell hyperplasia and appendiceal carcinoids. J Pathol 1988, 156(4):325-329.
62. Moyana T.N., Satkunam N. A comparative immunohistochemical study of jejunoileal and appendiceal carcinoids. Implications for histogenesis and pathogenesis. Cancer 1992, 70(5):1081-1088.
63. Gledhill A., Hall P.A., Cruse J.P., et al. Enteroendocrine cell hyperplasia, carcinoid tumours and adenocarcinoma in long-standing ulcerative colitis. Histopathology 1986, 10(5):501-508.
64. Hock Y.L., Scott K.W., Grace R.H. Mixed adenocarcinoma/carcinoid tumour of large bowel in a patient with Crohn's disease. J Clin Pathol 1993, 46(2):183-185.
65. Matsumoto T., Jo Y., Mibu R., et al. Multiple microcarcinoids in a patient with long standing ulcerative colitis. J Clin Pathol 2003, 56(12):963-965.
66. Nascimbeni R., Villanacci V., Di Fabio F., et al. Solitary microcarcinoid of the rectal stump in ulcerative colitis. Neuroendocrinology 2005, 81(6):400-404.
67. Fiocca R., Rindi G., Capella C., et al. Glucagon, glicentin, proglucagon, PYY, PP and proPP-icosapeptide immunoreactivities of rectal carcinoid tumors and related non-tumor cells. Regul Pept 1987, 17(1):9-29.
68. O'Kane A.M., O'Donnell M.E., Shah R., et al. Small cell carcinoma of the appendix. World J Surg Oncol 2008, 6:4.
69. Rossi G., Bertolini F., Sartori G., et al. Primary mixed adenocarcinoma and small cell carcinoma of the appendix: a clinicopathologic, immunohistochemical, and molecular study of a hitherto unreported tumor. Am J Surg Pathol 2004, 28(9):1233-1239.
70. Bernick P.E., Klimstra D.S., Shia J., et al. Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum 2004, 47(2):163-169.
71. Anthony P.P., Drury R.A. Elastic vascular sclerosis of mesenteric blood vessels in argentaffin carcinoma. J Clin Pathol 1970, 23(2):110-118.
72. La Rosa S., Chiaravalli A.M., Capella C., et al. Immunohistochemical localization of acidic fibroblast growth factor in normal human enterochromaffin cells and related gastrointestinal tumours. Virchows Arch 1997, 430(2):117-124.
73. Nilsson O., Wangberg B., McRae A., et al. Growth factors and carcinoid tumours. Acta Oncol 1993, 32(2):115-124.
74. Papotti M., Bongiovanni M., Volante M., et al. Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis. Virchows Arch 2002, 440(5):461-475.
75. La Rosa S., Rigoli E., Uccella S., et al. CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors. Virchows Arch 2004, 445(3):248-254.
76. Canavese G., Azzoni C., Pizzi S., et al. p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior. Hum Pathol 2001, 32(10):1094-1101.
77. Shia J., Tang L.H., Weiser M.R., et al. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?. Am J Surg Pathol 2008, 32(5):719-731.
78. Schottenfeld D., Beebe-Dimmer J.L., Vigneau F.D. The epidemiology and pathogenesis of neoplasia in the small intestine. Ann Epidemiol 2009, 19(1):58-69.
79. Modlin I.M., Champaneria M.C., Chan A.K., et al. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress. Am J Gastroenterol 2007, 102(7):1464-1473.
80. Zhao J., de Krijger R.R., Meier D., et al. Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors (carcinoids): marked differences indicating diversity in molecular pathogenesis. Am J Pathol 2000, 157(5):1431-1438.
81. Tonnies H., Toliat M.R., Ramel C., et al. Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation. Gut 2001, 48(4):536-541.
82. Moertel C.G., Dockerty M.B. Familial occurrence of metastasizing carcinoid tumors. Ann Intern Med 1973, 78(3):389-390.
83. Moertel C.G., Sauer W.G., Dockerty M.B., et al. Life history of the carcinoid tumor of the small intestine. Cancer 1961, 14:901-912.
84. Godwin J.D. Carcinoid tumors. An analysis of 2,837 cases. Cancer 1975, 36(2):560-569.
85. Burke A.P., Thomas R.M., Elsayed A.M., et al. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases. Cancer 1997, 79(6):1086-1093.
86. Lyss A.P. Appendiceal malignancies. Semin Oncol 1988, 15(2):129-137.
87. Marudanayagam R., Williams G.T., Rees B.I. Review of the pathological results of 2660 appendicectomy specimens. J Gastroenterol 2006, 41(8):745-749.
88. Yao J.C., Hassan M., Phan A., et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008, 26(18):3063-3072.
89. Moertel C.G., Dockerty M.B., Judd E.S. Carcinoid tumors of the vermiform appendix. Cancer 1968, 21(2):270-278.
90. Goede A.C., Caplin M.E., Winslet M.C. Carcinoid tumour of the appendix. Br J Surg 2003, 90(11):1317-1322.
91. Stinner B., Rothmund M. Neuroendocrine tumours (carcinoids) of the appendix. Best Pract Res Clin Gastroenterol 2005, 19(5):729-738.
92. Konishi T., Watanabe T., Kishimoto J., et al. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut 2007, 56(6):863-868.
93. Modlin I.M., Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997, 79(4):813-829.
94. Berardi R.S. Carcinoid tumors of the colon (exclusive of the rectum): review of the literature. Dis Colon Rectum 1972, 15(5):383-391.
95. Kwaan M.R., Goldberg J.E., Bleday R. Rectal carcinoid tumors: review of results after endoscopic and surgical therapy. Arch Surg 2008, 143(5):471-475.
96. Rosenberg J.M., Welch J.P. Carcinoid tumors of the colon. A study of 72 patients. Am J Surg 1985, 149(6):775-779.
97. Stinner B., Kisker O., Zielke A., et al. Surgical management for carcinoid tumors of small bowel, appendix, colon, and rectum. World J Surg 1996, 20(2):183-188.
98. Modlin I.M., Lye K.D., Kidd M.A. 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003, 97(4):934-959.
99. Brenner B., Tang L.H., Shia J., et al. Small cell carcinomas of the gastrointestinal tract: clinicopathological features and treatment approach. Semin Oncol 2007, 34(1):43-50.